Daniil Gataulin
Stock Analyst at H.C. Wainwright
(2.26)
# 3,158
Out of 5,104 analysts
74
Total ratings
32.8%
Success rate
1.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WATT Energous | Initiated Coverage: Buy | $15 | $8.14 | +84.28% | 2 | Oct 27, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $21 → $23 | $7.14 | +222.13% | 3 | Jun 25, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $11 → $13 | $4.27 | +204.45% | 3 | Jun 17, 2026 | |
| CRVO CervoMed | Reiterated: Buy | $21 | $1.56 | +1,246.15% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $9.42 | +271.55% | 2 | May 14, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $7.28 | +628.02% | 3 | May 12, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $98.51 | -38.08% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $0.6833 | +485.39% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $0.8745 | +700.46% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $4.02 | +173.63% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $0.395 | +7,241.77% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $23.03 | +60.66% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.71 | +574.45% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $0.4621 | +116.40% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.33 | +269.52% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $2.02 | +840.59% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0692 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.62 | n/a | 2 | Feb 15, 2023 |
Energous
Oct 27, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $8.14
Upside: +84.28%
Ocular Therapeutix
Jun 25, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $7.14
Upside: +222.13%
Opus Genetics
Jun 17, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $4.27
Upside: +204.45%
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $1.56
Upside: +1,246.15%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $9.42
Upside: +271.55%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $7.28
Upside: +628.02%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $98.51
Upside: -38.08%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $0.6833
Upside: +485.39%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $0.8745
Upside: +700.46%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $4.02
Upside: +173.63%
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $0.395
Upside: +7,241.77%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $23.03
Upside: +60.66%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $7.71
Upside: +574.45%
Jan 2, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $0.4621
Upside: +116.40%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $4.33
Upside: +269.52%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $2.02
Upside: +840.59%
Jun 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0692
Upside: n/a
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $16.62
Upside: n/a